Compare Marvell Technology Inc (MRVL) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Marvell Technology Inc trades at $211.74 (market cap $171.11B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Marvell Technology Inc is far larger — about 2.4× Regeneron Pharmaceuticals Inc's market cap, and Regeneron Pharmaceuticals Inc pays the higher dividend (0.56%). Which is the better fit depends on your goals.
| MRVL | REGN | |
|---|---|---|
Market Cap | $171.11B | $70.47B |
Sector | Technology | Health |
52-Week High | $316.43 | $812.27 |
52-Week Low | $62.31 | $545.46 |
Enterprise Value | $172.55B | $64.42B |
Dividend Yield | 0.12% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
